PET Imaging of Bromodomain and Extra-Terminal Domain Inhibitors for the Noninvasive Assessment of Metabolic Changes in the Liver and Brain of Early-Stage Alcoholic Liver Disease

Alcoholic liver disease (ALD) has a significant impact on human health and is one of the leading causes of liver disease mortality. The early and exact diagnosis of ALD is very important since the early stage of disease progression can be reversible. Although ALD can be evaluated by ultrasound, CT, or MRI, there is still no imaging technique sufficient in the diagnosis of early-stage ALD. Of the current studies, epigenetic modulation plays a significant role in the development and progression of ALD. In this work, we evaluate whether BRDs play a vital role in the early-stage ALD using our new PET imaging probe of BET proteins, [C-11]CW22. PET/CT imaging of [C-11]CW22 and [F-18]FDG was used to identify early-stage lesions of livers and brains in the mice model. We found that the average uptake values of livers and brains in early-stage ALD were significantly increased for [C-11]CW22 PET/CT imaging but only slightly changed in [F-18]FDG PET/CT imaging. Consistently, we also found that BRD 3, 4 protein expression levels were significantly higher in the liver and brain tissues of early-stage ALD. Furthermore, through Pmod software, we found that [C-11]CW22 PET/CT uptakes in the brain stem, cerebellum, and midbrain were significantly up-regulated in the early-stage ALD. In conclusion, BRDs were important mediators of damage in early-stage ALD. [C-11]CW22 PET/CT imaging can detect the early-phase alcohol-induced damage of livers and brains, which will likely lead to human trials in the future.

Automated summary

Alcoholic liver disease (ALD) is a major cause of liver disease mortality and has a significant impact on human health. Early and accurate diagnosis of ALD is crucial as the early stage of the disease can be reversible. Currently, there is no imaging technique that is sufficient for the diagnosis of early-stage ALD. Epigenetic modulation plays a significant role in the development and progression of ALD. This study evaluated the role of BET proteins in early-stage ALD using a new PET imaging probe called [C-11]CW22. The results showed that [C-11]CW22 PET/CT imaging can detect early-phase alcohol-induced damage in the liver and brain.